Theranos

Theranos is a biotechnology company founded by Elizabeth Holmes in 2003. The company claimed to have revolutionized blood testing by developing a proprietary technology that could quickly and accurately conduct a wide range of tests using just a few drops of blood obtained through a fingerstick.

However, in 2015, a series of investigative articles by journalist John Carreyrou in The Wall Street Journal raised serious doubts about the accuracy and reliability of Theranos' technology. The articles alleged that the company misled investors, patients, and doctors about the capabilities of its blood-testing technology. Subsequent investigations revealed that Theranos' technology was far from being reliable and accurate as claimed.

Theranos headquartered in United States, North America, operates in the Biotechnology, Consumer, Health Care, Health Diagnostics sector. The company focuses on Biotechnology and has secured $219.0B in funding across 160 round(s). With a team of 101-250 employees, Theranos is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Theranos, raised $45.0M. Discover more about their projects, partnerships, and impact on our platform.